Dennis Kasper
#77,531
Most Influential Person Now
American microbiologist
Dennis Kasper's AcademicInfluence.com Rankings
Dennis Kasperbiology Degrees
Biology
#3613
World Rank
#5493
Historical Rank
#1448
USA Rank
Microbiology
#136
World Rank
#161
Historical Rank
#52
USA Rank
Immunology
#189
World Rank
#197
Historical Rank
#57
USA Rank
Download Badge
Biology
Why Is Dennis Kasper Influential?
(Suggest an Edit or Addition)According to Wikipedia, Dennis L. Kasper is an American microbiologist and immunologist, and the William Ellery Channing Professor of Medicine and Professor of Immunology at Harvard Medical School. He leads the Kasper Laboratory within the Blavatnik Institute in the Department of Immunology at Harvard Medical School. He was also executive dean for academic programs at Harvard Medical School and director of the Channing Laboratory Department of Medicine at Brigham and Women's Hospital.
Dennis Kasper's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System (2005) (2501)
- A microbial symbiosis factor prevents intestinal inflammatory disease (2008) (2085)
- Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". (2005) (2003)
- Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function (2012) (1393)
- How colonization by microbiota in early life shapes the immune system (2016) (1148)
- Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota (2012) (1007)
- Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. (1976) (635)
- Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells (2015) (598)
- Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen (2005) (546)
- Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae (2002) (502)
- Mining the Human Gut Microbiota for Immunomodulatory Organisms (2017) (473)
- Sphingolipids from a Symbiotic Microbe Regulate Homeostasis of Host Intestinal Natural Killer T Cells (2014) (446)
- Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. (1977) (439)
- Immunologic response of man to group B meningococcal polysaccharide vaccines. (1972) (437)
- A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease (2010) (419)
- Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis (2019) (397)
- A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip (2019) (381)
- The love–hate relationship between bacterial polysaccharides and the host immune system (2006) (336)
- The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. (1977) (327)
- Polysaccharide Processing and Presentation by the MHCII Pathway (2004) (323)
- Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression (2010) (316)
- Extensive surface diversity of a commensal microorganism by multiple DNA inversions (2001) (299)
- Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice (2016) (278)
- Structural features of polysaccharides that induce intra-abdominal abscesses. (1993) (271)
- A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design (2011) (267)
- Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. (1996) (256)
- Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci (1992) (254)
- A branched chain amino acid metabolite drives vascular transport of fat and causes insulin resistance (2016) (247)
- A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2 (2006) (245)
- Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. (1987) (230)
- Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. (2010) (224)
- HARRISON'S PRINCIPLES OF INTERNAL MEDICINE, 13TH EDITION: (2004) (223)
- Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. (1982) (220)
- Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. (2014) (219)
- Structural and Genetic Diversity of Group B Streptococcus Capsular Polysaccharides (2005) (216)
- Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. (1989) (215)
- How bacterial carbohydrates influence the adaptive immune system. (2010) (213)
- Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. (1999) (205)
- CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism 1 (2003) (199)
- Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. (1981) (196)
- Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. (2010) (194)
- Bacteroides fragilis subspecies in clinical isolates. (1977) (192)
- Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. (1990) (191)
- The role of specific antibody in alternative complement pathway- mediated opsonophagocytosis of type III, group B Streptococcus (1980) (187)
- Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species. (2011) (186)
- Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy. (1992) (186)
- Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. (1973) (182)
- Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules. (2014) (181)
- Microbiota-stimulated immune mechanisms to maintain gut homeostasis. (2010) (179)
- Bacterial Glycans: Key Mediators of Diverse Host Immune Responses (2006) (179)
- Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. (1999) (175)
- A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39+Foxp3+ T cells and Treg function (2015) (174)
- The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition. (1976) (173)
- Functional Analysis in Type Ia Group B Streptococcusof a Cluster of Genes Involved in Extracellular Polysaccharide Production by Diverse Species of Streptococci* (2001) (173)
- A Mechanism for Neurodegeneration Induced by Group B Streptococci through Activation of the TLR2/MyD88 Pathway in Microglia1 (2006) (168)
- Novel Engagement of CD14 and Multiple Toll-Like Receptors by Group B Streptococci1 (2001) (166)
- Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways1 (2002) (164)
- Moving beyond microbiome-wide associations to causal microbe identification (2017) (162)
- In vivo imaging and tracking of host–microbiota interactions via metabolic labeling of gut anaerobic bacteria (2015) (159)
- An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signaling (2014) (158)
- An Intestinal Organ Culture System Uncovers a Role for the Nervous System in Microbe-Immune Crosstalk (2017) (158)
- Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. (1996) (158)
- Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B Streptococcus (1988) (157)
- Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. (1983) (156)
- Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. (1992) (155)
- TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. (2008) (155)
- Zwitterionic Polysaccharides Stimulate T Cells by MHC Class II-Dependent Interactions1 (2002) (155)
- A review. Lessons from an animal model of intra-abdominal sepsis. (1978) (151)
- Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. (1989) (148)
- Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus1 (2005) (147)
- Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. (1977) (143)
- Harrisons principles of internal medicine - 15th edition (2001) (130)
- The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA (2012) (128)
- Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. (1977) (123)
- Group B streptococcal vaccines. (1985) (122)
- The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. (1992) (121)
- Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. (2000) (121)
- Vitamin and trace Mineral Deficiency and Excess (2008) (121)
- Regulation of Virulence by a Two-Component System in Group B Streptococcus (2005) (120)
- Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. (2014) (119)
- Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine (2010) (117)
- Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. (1976) (115)
- Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen. (1987) (114)
- T Cells Activated by Zwitterionic Molecules Prevent Abscesses Induced by Pathogenic Bacteria* (2000) (111)
- Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons (2013) (111)
- Transcriptional and proteomic insights into the host response in fatal COVID-19 cases (2020) (110)
- Cognate Stimulatory B-Cell–T-Cell Interactions Are Critical for T-Cell Help Recruited by Glycoconjugate Vaccines (1999) (108)
- Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. (1982) (107)
- Regulation of surface architecture by symbiotic bacteria mediates host colonization (2008) (105)
- Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis (1991) (105)
- Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. (1981) (103)
- Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine (1993) (103)
- Deciphering the tête-à-tête between the microbiota and the immune system. (2014) (102)
- Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity (1991) (101)
- Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. (1979) (100)
- Commensal Microbiota Modulation of Natural Resistance to Virus Infection (2020) (99)
- Cellular immunity to Bacteroides fragilis capsular polysaccharide (1982) (98)
- A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci (1991) (97)
- Immunodeterminant specificity of human immunity to type III group B streptococcus (1979) (96)
- Polysaccharide Biosynthesis Locus Required for Virulence of Bacteroides fragilis (2001) (95)
- Isolation and identification of encapsulated strains of Bacteroides fragilis. (1977) (95)
- A commensal bacterial product elicits and modulates migratory capacity of CD39+ CD4 T regulatory subsets in the suppression of neuroinflammation (2014) (95)
- Small Molecule Control of Virulence Gene Expression in Francisella tularensis (2009) (95)
- Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae. (1980) (94)
- Bacterial capsule--old dogmas and new tricks. (1986) (93)
- Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. (1998) (93)
- Coming of age: carbohydrates and immunity (2005) (93)
- CD4+ T Cells Regulate Surgical and Postinfectious Adhesion Formation (2002) (93)
- Characterization of the Linkage between the Type III Capsular Polysaccharide and the Bacterial Cell Wall of Group BStreptococcus * (2000) (92)
- Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. (2004) (92)
- Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease. (1980) (92)
- Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine (1994) (92)
- Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus. (1978) (91)
- Immunogenicity of polysaccharides from type III, group B Streptococcus. (1978) (91)
- Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization (1983) (91)
- Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. (1994) (90)
- Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. (2003) (90)
- Impaired Antibody Response to Group B Streptococcal Type III Capsular Polysaccharide in C3- and Complement Receptor 2-Deficient Mice1 (2003) (89)
- Experimental animal models for anaerobic infections. (1979) (89)
- Structural and Immunochemical Characterization of the Type VIII Group B Streptococcus Capsular Polysaccharide (*) (1996) (87)
- Comprar Harrison's Principles of Internal Medicine. 18th Ed. 2 Volúmenes | Dennis Kasper | 9780071748896 | Mcgraw-Hill Education (2011) (86)
- Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus. (1983) (86)
- Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection. (1977) (86)
- NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives. (1997) (85)
- Structure, conformation and immunology of sialic acid-containing polysaccharides of human pathogenic bacteria (1984) (85)
- Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. (1992) (84)
- Carbohydrates and T cells: a sweet twosome. (2013) (83)
- Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. (1999) (83)
- Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus. (1980) (82)
- Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. (1982) (82)
- Immunochemical characterization of the outer membrane complex of Bacteroides fragilis subspecies fragilis. (1975) (81)
- Microreview: Zwitterionic capsular polysaccharides: the new MHCII‐dependent antigens (2005) (81)
- Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide. (1991) (81)
- Purification and immunochemical characterization of the outer membrane complex of Bacteroides melaninogenicus subspecies asaccharolyticus. (1977) (80)
- Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus (1976) (79)
- Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus. (1983) (78)
- A maternal vaccine against group B Streptococcus: past, present, and future. (2013) (78)
- Microbial carbohydrate depolymerization by antigen-presenting cells: Deamination prior to presentation by the MHCII pathway (2008) (76)
- Neonatal mouse model of group B streptococcal infection. (1992) (76)
- An Immunologic Mode of Multigenerational Transmission Governs a Gut Treg Setpoint (2020) (76)
- Quantitative determination of antibodies to type III group B streptococcal polysaccharide. (1996) (75)
- Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide (1989) (75)
- A Defined O-Antigen Polysaccharide Mutant of Francisella tularensis Live Vaccine Strain Has Attenuated Virulence while Retaining Its Protective Capacity (2007) (74)
- Isolation and Characterization of a Native Cell Wall Complex from Neisseria meningitidis (1972) (73)
- Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II‐dependent pathway for antigen presentation (2009) (72)
- Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. (1986) (72)
- Adherence of Bacteroides fragilis in vivo (1978) (70)
- Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein (1992) (70)
- Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. (1995) (70)
- The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus. (1980) (69)
- Structural Properties of Group B Streptococcal Type III Polysaccharide Conjugate Vaccines That Influence Immunogenicity and Efficacy (1998) (68)
- Inactivation of the α C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus (1997) (68)
- Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. (1973) (67)
- Phenotypic diversity in the alpha C protein of group B streptococci (1991) (67)
- Microbiota-targeted maternal antibodies protect neonates from enteric infection (2020) (67)
- Microcapsule of type III strains of group B Streptococcus: production and morphology (1976) (67)
- The Starting Lineup: Key Microbial Players in Intestinal Immunity and Homeostasis (2011) (66)
- Immunologic Memory Induced by a Glycoconjugate Vaccine in a Murine Adoptive Lymphocyte Transfer Model (1998) (65)
- Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines (2018) (64)
- Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins. (1982) (64)
- Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. (2008) (64)
- IFN-γ Regulated Chemokine Production Determines the Outcome of Staphylococcus aureus Infection1 (2008) (63)
- Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. (1979) (62)
- Alpha C Protein as a Carrier for Type III Capsular Polysaccharide and as a Protective Protein in Group B Streptococcal Vaccines (1999) (61)
- Illuminating Vital Surface Molecules of Symbionts in Health and Disease (2017) (61)
- Zwitterionic Polysaccharides Stimulate T Cells with No Preferential Vβ Usage and Promote Anergy, Resulting in Protection against Experimental Abscess Formation1 (2004) (59)
- Symbionts exploit complex signaling to educate the immune system (2019) (58)
- Effect of Molecular Size on the Ability of Zwitterionic Polysaccharides to Stimulate Cellular Immunity1 (2000) (58)
- Bacteroides fragilis NCTC9343 Produces at Least Three Distinct Capsular Polysaccharides: Cloning, Characterization, and Reassignment of Polysaccharide B and C Biosynthesis Loci (2000) (57)
- Structure-function relationships for polysaccharide-induced intra-abdominal abscesses (1994) (56)
- Resident commensals shaping immunity. (2013) (56)
- A model of high-affinity antibody binding to type III group B Streptococcus capsular polysaccharide. (1987) (56)
- Systemic toll‐like receptor ligands modify B‐cell responses in human inflammatory bowel disease (2011) (56)
- Isolation and characterization of type IV group B Streptococcus capsular polysaccharide (1989) (56)
- Structure of the complex group-specific polysaccharide of group B Streptococcus. (1987) (56)
- An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus. (1990) (56)
- The changing spectrum of group B streptococcal disease. (1993) (56)
- Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation (1994) (55)
- Analysis of a Capsular Polysaccharide Biosynthesis Locus of Bacteroides fragilis (1999) (55)
- Mouse protection test for group B Streptococcus type III. (1979) (54)
- Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens. (1980) (53)
- Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus. (1982) (53)
- Multiantennary group-specific polysaccharide of group B Streptococcus. (1988) (53)
- Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro. (1999) (53)
- Surface antigens as virulence factors in infection with Bacteroides fragilis. (1979) (53)
- Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines (2001) (52)
- Conjugate vaccines against group B Streptococcus types IV and VII. (2002) (52)
- Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice (1982) (51)
- A unique structural pattern shared by T-cell-activating and abscess-regulating zwitterionic polysaccharides. (2002) (51)
- Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. (1979) (51)
- Type III Group B Streptococcal Polysaccharide Induces Antibodies That Cross-React with Streptococcus pneumoniae Type 14 (2002) (51)
- Isolation and Chemical Characterization of a Capsular Polysaccharide Antigen Shared by Clinical Isolates ofEnterococcus faecalis and Vancomycin-ResistantEnterococcus faecium (1999) (51)
- Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. (1995) (50)
- IL-2 mediates protection against abscess formation in an experimental model of sepsis. (1999) (50)
- Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen. (1980) (49)
- Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy. (1995) (49)
- Group A streptococcus epidemiology and vaccine implications. (2007) (48)
- Immunogenicity and protective efficacy of the alpha C protein of group B streptococci are inversely related to the number of repeats (1997) (48)
- Biological chemistry of immunomodulation by zwitterionic polysaccharides. (2003) (46)
- Glycoconjugate vaccines to prevent group B streptococcal infections (2003) (46)
- Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide. (1983) (45)
- Colonization with group B streptococci in girls under 16 years of age. (1977) (45)
- Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis. (2009) (44)
- Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. (1995) (44)
- Immunochemical characterization of native polysaccharides from group B streptococcus: the relationship of the type III and group B determinants. (1978) (44)
- Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs (1988) (44)
- IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection. (2008) (43)
- Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. (1977) (43)
- The atypical lipopolysaccharide of Francisella. (2013) (43)
- Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine (1992) (42)
- Effect of B7-2 and CD40 Signals from Activated Antigen-Presenting Cells on the Ability of Zwitterionic Polysaccharides To Induce T-Cell Stimulation (2005) (41)
- Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus. (1997) (41)
- The role of complement and antibody in opsonophagocytosis of type II group B streptococci. (1986) (41)
- Bacteroides fragilis-stimulated interleukin-10 contains expanding disease. (2011) (41)
- Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate. (2000) (40)
- Electron microscopic definition of surface antigens of group B Streptococcus. (1979) (40)
- Role of T cells in abscess formation. (2002) (39)
- Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. (2005) (39)
- Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus. (1977) (39)
- A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. (1985) (38)
- The cell envelope of the Legionnaires' disease bacterium. Morphologic and biochemical characteristics. (1979) (38)
- Legionella pneumophila: growth inhibition by human pharyngeal flora. (1980) (37)
- A novel mechanism for glycoconjugate vaccine activation of the adaptive immune system (2011) (37)
- Immunochemical and Biological Characterization of Three Capsular Polysaccharides from a Single Bacteroides fragilisStrain (2001) (36)
- The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1β-induced inflammation in human fetal enterocytes via toll receptors 2 and 4 (2017) (36)
- Harrison's Infectious Diseases (2010) (36)
- Characterization of the O-antigen Polymerase (Wzy) of Francisella tularensis* (2010) (36)
- Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine (1994) (35)
- Identification of sialic acid in polysaccharide antigens in group B Streptococcus (1976) (35)
- Symbiotic commensal bacteria direct maturation of the host immune system (2008) (35)
- Animal model system for studying virulence of and host response to Bacteroides fragilis. (1990) (35)
- Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching (2008) (35)
- Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701. (2004) (35)
- Host immunomodulatory lipids created by symbionts from dietary amino acids (2021) (34)
- Isolation of carbohydrate-specific CD4+ T cell clones from mice after stimulation by two model glycoconjugate vaccines (2012) (34)
- Antibody to group B Streptococcus type III in human sera measured by a mouse protection test (1981) (33)
- Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine. (2012) (33)
- Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII. (1999) (33)
- Finding a needle in a haystack: Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor (2018) (33)
- Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection. (1990) (32)
- Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators. (1998) (32)
- 4,8-anhydro-N-acetylneuraminic acid. Isolation from edible bird's nest and structure determination. (1987) (32)
- Bacteroides fragilis strains express multiple capsular polysaccharides (1993) (32)
- Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. (2002) (32)
- Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation. (1977) (32)
- Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons (1996) (31)
- The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice. (1982) (30)
- Lymphocyte macrophage interactions in the response to surgical infections. (1987) (30)
- Structure of the capsular polysaccharide antigen of type IV group B Streptococcus (1989) (30)
- Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. (2002) (30)
- Group B streptococcal colonization and antibody status in lower socioeconomic parturient women. (1979) (30)
- Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination. (2009) (29)
- Mutations affecting the activity of toxic shock syndrome toxin-1. (1994) (28)
- Case records of the Massachusetts General Hospital. Case 25-2005. A 40-year-old man with prolonged fever and weight loss. (2005) (28)
- Antibody-independent activation of C1 by type Ia group B streptococci. (1982) (28)
- TWO UNLINKED GENETIC LOCI INTERACT TO CONTROL THE HUMAN IMMUNE RESPONSE TO TYPE III GROUP B STREPTOCOCCAL ANTIGEN (1984) (28)
- RAPID DIAGNOSIS OF BACTEROIDES INFECTIONS BY INDIRECT IMMUNOFLUORESCENCE ASSAY OF CLINICAL SPECIMENS (1979) (28)
- Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides. (1985) (27)
- Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria. (1983) (27)
- Regulation of T cells by gut commensal microbiota (2011) (27)
- Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay (1984) (26)
- The role of anaerobic bacteria in abscess formation. (1982) (26)
- Structure of the Type VI Group B Streptococcus Capsular Polysaccharide Determined by High Resolution NMR Spectroscopy (1994) (25)
- Structure and serology of the native polysaccharide antigen of type Ia group B streptococcus. (1980) (25)
- Identification of a subspecies-specific capsular antigen from Bacteroides melaninogenicus subspecies asaccharolyticus by immunofluorescence and electron microscopy. (1978) (25)
- Kdo Hydrolase Is Required for Francisella tularensis Virulence and Evasion of TLR2-Mediated Innate Immunity (2013) (24)
- Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling. (2003) (24)
- Immunochemical characterization of surface antigens of Bacteroides melaninogenicus. (1979) (24)
- Interactions between the intestinal microbiota and innate lymphoid cells (2014) (24)
- Bactericidal Antibody Assay Using 14C-Labeled Neisseria meningitidis 1 (1972) (23)
- T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses. (1990) (23)
- Isolation of a serogroup 1-specific antigen from Legionella pneumophila. (1982) (23)
- SEROLOGICAL EVIDENCE FOR THE ROLE OF BACTEROIDES FRAGILIS AND ENTEROBACTERIACEAE IN THE PATHOGENESIS OF ACUTE PELVIC INFLAMMATORY DISEASE (1981) (23)
- Quantitative determination of the serum antibody response to the capsular polysaccharide of Bacteroides fragilis subspecies fragilis in women with pelvic inflammatory disease. (1978) (22)
- A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III. (2018) (22)
- Molecular analysis of two group B streptococcal virulence factors. (1990) (22)
- Reviews of Infectious Diseases (2016) (21)
- 3-Deoxy-d-manno-octulosonic Acid (Kdo) Hydrolase Identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila* (2010) (21)
- Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis (2019) (21)
- Interstrain Variation of the Polysaccharide B Biosynthesis Locus of Bacteroides fragilis: Characterization of the Region from Strain 638R (1999) (20)
- Group A and group B streptococcal vaccine development. A round table presentation. (1997) (20)
- Harnessing Colon Chip Technology to Identify Commensal Bacteria That Promote Host Tolerance to Infection (2020) (20)
- Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates (1995) (20)
- Relevance of Commensal Microbiota in the Treatment and Prevention of Inflammatory Bowel Disease (2013) (20)
- Potentiation of virulence by group B streptococcal polysaccharides. (1984) (20)
- Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice. (1997) (19)
- Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody. (1986) (19)
- The alpha-L-(1----2)-trirhamnopyranoside epitope on the group-specific polysaccharide of group B streptococci (1991) (18)
- Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model. (1982) (18)
- Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1 (1985) (18)
- Orientations of the Bacteroides fragilis Capsular Polysaccharide Biosynthesis Locus Promoters during Symbiosis and Infection (2010) (18)
- Surface Structures of Group B Streptococcus Important in Human Immunity. (2019) (17)
- Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber (1989) (17)
- GROUP B STREPTOCOCCAL VACCINES (1986) (17)
- Genetic Diversity of the Capsular Polysaccharide C Biosynthesis Region of Bacteroides fragilis (2000) (16)
- Building conventions for unconventional lymphocytes (2017) (16)
- Virulence factors in infections with bacteroides fragilis: isolation and characterization of capsular polysaccharide and lipopolysaccharide. (1982) (16)
- Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway. (1986) (16)
- Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis. (1984) (16)
- Complex human gut microbiome cultured in anaerobic human intestine chips (2018) (16)
- Meningococcal infections. 3. Studies of group A polysaccharide vaccines. (1971) (16)
- Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis. (1984) (16)
- Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria. (2010) (15)
- Role of Murine Intestinal Interleukin-1 Receptor 1-Expressing Lymphoid Tissue Inducer-Like Cells in Salmonella Infection (2013) (15)
- A Possible Role of Bacterial Antigens in the Pathogenesis of Autoimmune Thyroid Disease (1987) (15)
- Comprar Harrison's Principles of Internal Medicine, Self-Assessment and Board Review | Joseph Loscalzo | 9780071496193 | Mcgraw-Hill Education (2008) (15)
- Antibody responses in invasive group B streptococcal infection in adults. (1998) (15)
- Detection of anticapsular antibodies to Bacteroides asaccharolyticus in serum from rabbits and humans by use of an enzyme-linked immunosorbent assay. (1979) (15)
- A Novel Approach to N-Acetyl-neuraminic Acid-Containing Oligosaccharides. Synthesis of a Glycosyl Donor Derivative of α-N-Acetyl-D-neuraminyl- (2-6) -D-galactose (1987) (15)
- Antibody to type III group B Streptococcus in the rhesus monkey. (1983) (15)
- Characterization of Bacteroides fragilis strains based on antigen-specific immunofluorescence. (1983) (14)
- Vaccination as a measure for prevention of neonatal GBS infection. (1985) (14)
- Group B streptococcus infection in mother and child. (1991) (14)
- Virulence factors of anaerobic bacteria: an overview. (1979) (14)
- Measurement of Human Antibodies to Type III Group BStreptococcus (1999) (14)
- Affinity chromatography of anti-meningococcal antiserum. (1972) (14)
- Tetanus toxoid stimulation of the hypothalamic-pituitary-adrenal axis correlates inversely with the increase in tetanus toxoid antibody titers. (1998) (12)
- The role of complement in opsonization of GBS. (1985) (12)
- Nociceptor neurons direct goblet cells via a CGRP-RAMP1 axis to drive mucus production and gut barrier protection (2022) (12)
- Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide. (1986) (12)
- Intracellular expression of toxic shock syndrome toxin 1 in Saccharomyces cerevisiae (1994) (10)
- Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages. (2011) (10)
- Bacterial structure and functional relation to abscess formation. (1994) (10)
- 244 – Anaerobic Infections: General Concepts (2015) (9)
- Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by Bacteroides fragilis’ Polysaccharide A (2021) (8)
- Harrison's Infectious Diseases, 2/E (2013) (8)
- Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells. (2005) (8)
- Comprar Harrison's Infectious Diseases | Anthony S. Fauci | 9780071702935 | Mcgraw-Hill Education (2010) (7)
- Testosterone: more than having the guts to win the Tour de France. (2013) (7)
- Immune T cells prevent bacteroides fragilis abscesses. (1983) (7)
- Structural characterization of two surface polysaccharides of Bacteroides fragilis. (1991) (7)
- Comparison of assays for antibody to group B Streptococcus, type III. (1980) (7)
- Veggies and Intact Grains a Day Keep the Pathogens Away (2016) (7)
- CHARACTERIZATION OF THE "NATIVE" TYPE III POLYSACCHARIDE OF GROUP B STREPTOCOCCUS* (1976) (6)
- Group B Streptococcus Type III Glycoconjugate Vaccines (1992) (6)
- Comprar Harrison's Manual of Medicine | Dennis Kasper | 9780071477437 | Mcgraw-Hill Education (2009) (6)
- Designer vaccines to prevent infections due to group B Streptococcus. (1995) (6)
- 5 – Role of Bacterial Virulence Factors in Pathogenesis of Anaerobic Infections (1989) (6)
- Structural elucidation of the capsular polysaccharide of Bacteroides fragilis strain 23745M1. (1995) (5)
- Edward Harold Kass, MD, PhD (1996) (5)
- Comprar Harrison's Manual Of Medicine 19th Ed. | D. Kasper | 9780071828529 | MCGRAW HILL (2016) (5)
- Enzyme-linked immunosorbent assay for measurement of antibody to type III group B streptococci (1982) (5)
- Traffic control at the “Gut-GALT crossroads” (2013) (5)
- Early Interactions of Murine Macrophages with Francisella tularensis Map to Mouse Chromosome 19 (2016) (5)
- Wild gut microbiota protects from disease (2017) (5)
- Microbial-host interaction: tolerance versus allergy. (2009) (5)
- The developmentally regulated fetal enterocyte gene, ZP4, mediates anti-inflammation by the symbiotic bacterial surface factor polysaccharide A on B. fragilis. (2019) (5)
- Sequence of the toxic shock syndrome toxin gene (tstH) borne by strains of Staphylococcus aureus isolated from patients with Kawasaki syndrome (1996) (4)
- Approach to the Acutely Ill Infected Febrile Patient Approach to the Acutely Ill Infected Febrile Patient (2015) (4)
- Cell structure and antigenic composition of GBS. (1985) (4)
- Correct structure of repeating unit of group B Streptococcus type III capsular polysaccharide. (1990) (4)
- Comprar Harrison Manual de Medicina Interna 18ed | Dan Longo | 9786071509505 | Mcgraw-Hill Interamericana (2013) (4)
- Type I interferon signaling restrains IL-10R+ colonic macrophages and dendritic cells and leads to more severe Salmonella colitis (2017) (4)
- What is it? Case 4, 1986. (1986) (4)
- Immunomodulation by zwitterionic polysaccharides (2010) (4)
- Infectious Disease Rounds: Respiratory Embarassment and Neurologic Symptoms in a Patient with AIDS (1988) (3)
- Immune mechanisms in the prevention of intra-abdominal abscess formation. (1989) (3)
- A Single Polysaccharide from the Human Commensal Bacteroides fragilis Protects Against Experimental CNS Demyelinating Disease (2010) (3)
- Alternative mechanism for glycoconjugate vaccine activation of the adaptive immune system (52.25) (2011) (3)
- Characterization of Serum Resistance of Neisseria gonorrhoeae (3)
- Immunization with a single-repeat alpha C protein may prevent escape of lower repeat mutants of group B Streptococcus. (1997) (3)
- Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology (2012) (2)
- Lack of stimulation of isohemagglutinin antibodies by immunization with group B streptococcal (type III) vaccine. (1981) (2)
- 1060 NEONATAL IMMUNITY TO TYPE HI GROUP B STREPTOCOCCAL (III-GBS) POLYSACCHARIDE FROM MATERNAL THIRD TRIMESTER VACCINATION (1985) (2)
- Infectious disease rounds: toxoplasmosis in a premature infant. (1988) (2)
- SAFETY AND IMMUNOGENICITY OF GROUP B STREPTOCOCCAL (GBS) POLYSACCHARIDE (PS) TYPES Ia AND Ib-TETANUS TOXOID (Ia-TT; Ib-TT) CONJUGATE VACCINES IN WOMEN.▴ 980 (1996) (2)
- Erratum: Moving beyond microbiome-wide associations to causal microbe identification (2018) (2)
- polysaccharide from type III, group B Streptococcus (1980) (2)
- Serum Antibody Response to Bacteroides fragilis in Women with Abscesses Follwing Hysterectomy (1980) (2)
- The Regulatory Function of B Cells in Protection Against EAE by a Human Commensal Bacteria Polysaccharide (P05.111) (2012) (1)
- Edward H. Kass, M.D., eulogy. (1990) (1)
- International Symposium on Anaerobic Bacteria and Bacterial Infections. Monte Carlo, Monaco, 25-28 September 1988. Proceedings. (1990) (1)
- Independent Signaling Pathways Differentiation Factor 88-Dependent and Streptococcus Involve Parallel Myeloid Bactericidal Activity Against Group B Cellular Activation , Phagocytosis , and (2002) (1)
- Molecular size affects antigenicity of type III, group B Streptococcus capsular polysaccharide. (1985) (1)
- conjugate vaccines against group B Streptococcal (1995) (1)
- Capsular and ‘O’ serotype determinants of Bacteroides fragilis (1982) (1)
- A paradigm for commensalism: the role of a specific microbial polysaccharide in health and disease. (2009) (1)
- Abstract IA18: Gut microbiota-host immunomodulatory interactions (2016) (1)
- BACTERICIDAL ANTIBODY TO NON-TYPABLE STRAINS OF HEMOPHILUS INFLUENZAE (1977) (1)
- Author Correction: A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip (2019) (1)
- When Lab Mice Go Wild, Fungi Are in Play. (2020) (1)
- Orientations of the Bacteroides fragilis Capsular Polysaccharide Biosynthesis Locus Promoters during Symbiosis and Infection (2012) (1)
- Interactions Cells by MHC Class II-Dependent Zwitterionic Polysaccharides Stimulate T (2002) (1)
- Inactivation of the a C protein antigen gene, bca, by a novel shuttleysuicide vector results in attenuation of virulence and immunity in group B Streptococcus (Streptococcus agalactiaeysurface antigensybacterial pathogenesisybacterial vaccines) (1997) (0)
- Understanding Microbial Sensing in Inflammatory Bowel Disease Using Click Chemistry (2016) (0)
- CORRECTION (2003) (0)
- Microbiota-targeted maternal antibodies protect neonates from enteric infection (2020) (0)
- A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip (2019) (0)
- T‐cell regulation of neutrophil trafficking during Staphylococcus aureus infections can regulate pathogenesis outcomes (2008) (0)
- Impact of the Host Microbiome on Vaccine Responsiveness: Lessons Learned and Future Perspective (2022) (0)
- Critical Role of Plasmacytoid Dendritic Cells in Commensal Microbial Polysaccharide‐Mediated Immunoregulation: O‐28 (2012) (0)
- Development of Vaccines to Prevent Wound Infections due to Anaerobic Bacteria (1988) (0)
- Kinetic and mechanistic diversity of intestinal immune homeostasis characterized by rapid removal of gut bacteria (2023) (0)
- Characterization of a DC Presenting a Microbial Polysaccharide to Regulatory T cells. (49.9) (2012) (0)
- Vitamin and Trace Mineral Deficiency and Excess (Chapter 326) (2018) (0)
- Abstract PR07: Bioorthogonal chemical labeling of specific immunomodulatory surface molecules in live commensals (2016) (0)
- QUETIAPINE INDUCED MYOCLONUS (2008) (0)
- Gut Commensal Immunomodulatory Factors: Identification and Structure‐Function Studies (2015) (0)
- Early life exposure to microbiota has persistent effects on colonic lamina propria iNKT cells and colitis: P-193. (2011) (0)
- Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance. (2023) (0)
- Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis (2019) (0)
- Concise review: the polypill in cardiovascular disease prevention (2007) (0)
- Inactivation of the a C protein antigen gene , bca , by a novel shuttle y suicide vector results in attenuation of virulence and immunity in group (1997) (0)
- Sphingolipids of Commensals Modulate Host Immunity through Regulation of iNKT Cells (2015) (0)
- Polysaccharide A Expression Depends on Bacteroides fragilis Commensal Disease Protection by the Human Central Nervous System Demyelinating (2010) (0)
- Publisher Correction: Host immunomodulatory lipids created by symbionts from dietary amino acids (2022) (0)
- Effects of Alum Adjuvant or a Booster Dose on Immunogenicityduring Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines (2002) (0)
- of the TLR2/MyD88 Pathway in Microglia by Group B Streptococci through Activation A Mechanism for Neurodegeneration Induced (2006) (0)
- Pseudohyponatremia in Multiple Myeloma (2010) (0)
- A defect in a small-intestinal lymphoid structure affects colonic B cell development (MUC8P.726) (2015) (0)
- Immunoassay for Nachweiss group B streptococcus (1992) (0)
- Vitamin D: a Health/Disease Switch in MS. (2010) (0)
- Commensal Bacteria Play an Important Role in Ulcerative Colitis via Bacterial Sphingolipids‐Mediated Regulation of Host Invariant Natural Killer T Cells: O‐16 YI (2012) (0)
- Microbiome induced complement synthesized in the gut protects against enteric infections (2023) (0)
- vaccine. by a polysaccharide-protein conjugate elicited polysaccharide of group B streptococci Functional activity of antibodies to the group B (2013) (0)
- Edward H. Kass, M.D., eulogy. (1990) (0)
- Characterization of the APC presenting a microbial polysaccharide to regulatory T cells. (2011) (0)
- Antigenic Specificity of Immune Cells (0)
- StreptococcusResponse to Group B Role of Lipoteichoic Acid in the (2009) (0)
- Glyco XIII: XIIIth International Symposium on Glycoconjugates (2005) (0)
- Modulation of host immune cell populations using gut microbiota (2018) (0)
- Response to Group B Streptococcus Role of Lipoteichoic Acid in the Phagocyte (2013) (0)
- Receptor 2-Deficient Mice Polysaccharide in C 3-and Complement Streptococcal Type III Capsular Impaired Antibody Response to Group B (2002) (0)
- 23027513GROUP B STREPTOCOCCUS INFECTION IN MOTHER AND CHILD (1991) (0)
- Bacteroides fragilis Formation by Cellular Mechanism of Intraabdominal Abscess (1998) (0)
- Publisher Correction: Host immunomodulatory lipids created by symbionts from dietary amino acids (2022) (0)
- Induction of T helper 1‐like regulatory are induced by Capsular polysaccharide A (PSA) of Bacteroides fragilis through IFN‐r and Foxp3 (2008) (0)
- Anatomically remote education of B cells is required for colonic health (2018) (0)
- Tu1962 Microbial Exposure During Early Life Has Persistent Effects on Tissue-Associated iNKT Cells and Their Function (2012) (0)
- environments. Immunological and NMR spectroscopic studies on these polysaccharides were (1984) (0)
- Edward H. Kass, 1917–1990 (1990) (0)
- GroupB Streptococcus TypeIIPolysaccharide-Tetanus (1992) (0)
- Immunochemical Characterization ofTwo Surface Polysaccharides ofBacteroides fragilis (1991) (0)
- Comprar Harrison’s Neurology in Clinical Medicine | Eugene Braunwald | 9780071741033 | Mcgraw-Hill Education (2010) (0)
- 895 ANTIBODY-INDEPENDENT CLASSICAL PATHWAY (CP)-MEDIATED OPSONOPHAGOCYTOSIS (OP) OF TYPE Ia GROUP B STREPTOCOCCI (IaGBS) (1981) (0)
- Comprar Harrison Manual de Medicina 19ª Ed. | D. Kasper | 9786071514097 | MCGRAW HILL (2017) (0)
- Abstract PR004: Tracking microbial sensing in colorectal cancer using bioorthogonal click chemistry (2016) (0)
- Bacterial antigens, antibodies, vaccines and their manufacturing. (1987) (0)
- from Strain 638 R : Characterization of the Region fragilis Bacteroides B Biosynthesis Locus of Interstrain Variation of the Polysaccharide (1999) (0)
- Mice Complement Receptor 2-Deficient Capsular Polysaccharide in C 3-and Group B Streptococcal Type III Impaired Antibody Response (2002) (0)
- The microbiome regulates the homeostasis of host invariant natural killer T (iNKT) cells (MUC4P.830) (2014) (0)
- Critical Role of Plasmacytoid Dendritic Cells in Commensal Microbial Polysaccharide‐Mediated Immunoregulation: P‐178 (2012) (0)
- Reactive Nitrogen species process a microbial carbohydrate presented by the MHCII Pathway (93.20) (2007) (0)
- Cellular Immunity Zwitterionic Polysaccharides to Stimulate Effect of Molecular Size on the Ability of (1999) (0)
- News updates (2001) (0)
- Diagnosis of pancreatic infection. (1988) (0)
- Immunity to group B Streptococcus (1986) (0)
- Group B Streptococcus type Ia polysaccharide-tetanus toxoid vaccine (1993) (0)
- Mechanisms of microbial synergy in intraabdominal abscess formation (1983) (0)
- DIFFERING USE OF NEUTROPHIL (PMN) RECEPTORS BY IMMUNOGLOBULIN G (IgG) ELICITED IN RESPONSE TO GROUP B STREPTOCOCCAL (GBS) TYPE III POLYSACCHARIDE(III-PS) OR GBS III-PS TETANUS TOXOID (III-TT) CONJUGATE VACCINES. (1996) (0)
- Preface Harrison's Manual of Medicine (2019) (0)
- IL-17-Dependent Mechanism Intra-abdominal Sepsis by an T Cells Mediate Abscess Formation in + CD 4 (2003) (0)
- Harrison's Online Updates (2001) (0)
- Group B streptococcur type II and type V polysaccharide-protein conjugate (1995) (0)
- Native Cell Wall Complex from Neisseria meningitidis (2003) (0)
- Streptococcus Response to Group B Role of Lipoteichoic Acid in the Phagocyte (2005) (0)
- Surface Structures of Group BStreptococcusImportant in Human Immunity (2019) (0)
- Beneficial bacteria that affect Toll-like receptors in the gut immune system : the case of PSA on Bacteroides fragilis and transcription profile of developmentally-regulated genes (2018) (0)
- A commensal microbial molecule confers protective anti-inflammatory responses employing both innate and cognate interactions (IRC5P.468) (2014) (0)
- Harrison's Infectious Diseases; Second Edition. (2013) (0)
- Olszak Natural Killer T Cell Function Microbial Exposure During Early Life Has Persistent Effects on (2012) (0)
- Contributors (2015) (0)
- Immunochemical Investigations of Cell Surface Antigens of Anaerobic Bacteria (1977) (0)
- Fiber Sets up the Battleground for Intestinal Prevotella. (2020) (0)
- Structure and Conformation of the Capsular Polysaccharides of Group B Streptococcus (1981) (0)
- Harnessing the immunogenicity of peptide-based glycoconjugate vaccines (2020) (0)
This paper list is powered by the following services:
Other Resources About Dennis Kasper
What Schools Are Affiliated With Dennis Kasper?
Dennis Kasper is affiliated with the following schools:
